4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Cost-effectiveness analysis of the treatment of end-stage renal disease in Brazil.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Cost-effectiveness analysis compared four treatments of end-stage renal disease in Brazil: continuous ambulatory peritoneal dialysis (CAPD), in-center hemodialysis (HD), cadaver donor transplantation (CD-Tx), and living related donor transplantation (LR-Tx). After 2 years, the costs per year of survival were CAPD, $12,134; HD, $10,065; CD-Tx, $6,978; and LR-Tx, $3,022. The HD cost was lower than CAPD partially because of the reuse of hemodialyzers in Brazil. Although less cost-effective, both dialysis treatments yielded more years of survival after 2 years. This analysis reveals a trade-off between cost per year of survival and years of survival.

          Related collections

          Author and article information

          Journal
          Int J Technol Assess Health Care
          International journal of technology assessment in health care
          Cambridge University Press (CUP)
          0266-4623
          0266-4623
          1990
          : 6
          : 1
          Affiliations
          [1 ] Escola Paulista de Medicina, Disciplina de Nefrologia, São Paulo, Brazil 04023.
          Article
          10.1017/s0266462300008965
          2113888

          Comments

          Comment on this article